Breast cancer screening programs have been in place in Europe since the late 1980s, as the results of studies have shown a 34% reduction in breast cancer-specific deaths [
1]. Two important events have had a major impact on breast screening performance: the replacement of film screening by digital mammography [
2] and the introduction of computerized supplemental intelligence to improve breast cancer detection. This field is rapidly evolving, and we are confronted with improvements in technology and imaging on an almost daily basis. Despite these technological achievements, some European countries still do not have population-based screening at a national level, and the process following a positive mammogram is inconsistent from institution to institution and from country to country, resulting in unequal patient care and varying efficiency of the healthcare system. …
